Larry Dillaha is Chief Medical Officer at Insys Therapeutics, Inc. (INSY). They have made 2 open-market trades across 2 companies since 2007, most recently 2014-03-05.
CIK 0001360463
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSY | SELL | 2014-03-05 | 2014-03-06 | $74.57 | $11.2M | -17.2% | -0.9% | -0.9% |
| SCRX | SELL · 10b5-1 | 2008-08-11 | 2008-08-12 | $20.34 | $18K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2008-04-25 | 2008-04-28 | $19.35 | $7K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2008-02-20 | 2008-02-22 | $22.54 | $20K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2008-01-23 | 2008-01-25 | $22.44 | $10K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2007-12-07 | 2007-12-10 | $22.75 | $58K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2007-10-10 | 2007-10-12 | $28.00 | $98K | N/A | N/A | N/A |
| SCRX | SELL | 2007-02-21 | 2007-02-23 | $23.89 | $40K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.